These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15067342)

  • 41. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
    Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up.
    Charpin C; Garcia S; Bouvier C; Martini F; Andrac L; Bonnier P; Lavaut MN; Allasia C
    Am J Clin Pathol; 1997 May; 107(5):534-41. PubMed ID: 9128265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endoglin (CD105) expression and angiogenesis status in small cell lung cancer.
    Takase Y; Kai K; Masuda M; Akashi M; Tokunaga O
    Pathol Res Pract; 2010 Nov; 206(11):725-30. PubMed ID: 20619547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies.
    Yu HK; Lee HJ; Choi HN; Ahn JH; Choi JY; Song HS; Lee KH; Yoon Y; Yi LS; Kim JS; Kim SJ; Kim TJ
    Clin Cancer Res; 2013 Oct; 19(19):5340-50. PubMed ID: 23922300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathologic significance of CD105 mRNA expression in human breast carcinoma].
    Pang D; Liu F; Xue YW; Zhang QF
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):38-40. PubMed ID: 15771797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of angiogenesis-stimulating factors (VEGF, CD31, CD105) and angiogenetic index in gingivae of patients with chronic periodontitis.
    Kasprzak A; Surdacka A; Tomczak M; Przybyszewska W; Seraszek-Jaros A; Malkowska-Lanzafame A; Siodla E; Kaczmarek E
    Folia Histochem Cytobiol; 2012; 50(4):554-64. PubMed ID: 23264219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neovascularity as a prognostic marker in renal cell carcinoma.
    Bauman TM; Huang W; Lee MH; Abel EJ
    Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
    Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
    Meunier-Carpentier S; Dales JP; Djemli A; Garcia S; Bonnier P; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2005 Apr; 26(4):977-84. PubMed ID: 15753992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance].
    Liu Y; Xue X; Wang F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):100-3. PubMed ID: 18476626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
    Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
    Front Immunol; 2018; 9():724. PubMed ID: 29719533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
    Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
    World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.